Selected research
Market Outlook & Growth Opportunities
Global Cosmetic In Vitro Testing Services Market Outlook and Growth Opportunities 2026
Market perspective
The global Cosmetic In Vitro Testing Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Cosmetic In Vitro Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Cosmetic In Vitro Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cosmetic In Vitro Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Cosmetic In Vitro Testing Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Cosmetic In Vitro Testing Services market include SGS, Intertek, Eurofins Scientific, Abich, XCellR8, ImQuest BioSciences, INVITRO-CONNECT, Labcorp and Bio-Rad Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Cosmetic In Vitro Testing Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cosmetic In Vitro Testing Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cosmetic In Vitro Testing Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cosmetic In Vitro Testing Services market.
Cosmetic In Vitro Testing Services Segment by Company
SGS
Intertek
Eurofins Scientific
Abich
XCellR8
ImQuest BioSciences
INVITRO-CONNECT
Labcorp
Bio-Rad Laboratories
Qiagen
GE Healthcare
Charles River Laboratories International
Catalent
Evotec Cyprotex
Promega
Gentronix Limited
Cosmetic In Vitro Testing Services Segment by Type
Biological Assays
Non-cell-based Assays
Cosmetic In Vitro Testing Services Segment by Application
Hair Care
Skin Care
Others
Cosmetic In Vitro Testing Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Cosmetic In Vitro Testing Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Cosmetic In Vitro Testing Services key companies, revenue, market share, and recent developments.
3. To split the Cosmetic In Vitro Testing Services breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Cosmetic In Vitro Testing Services market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Cosmetic In Vitro Testing Services significant trends, drivers, influence factors in global and regions.
6. To analyze Cosmetic In Vitro Testing Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cosmetic In Vitro Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cosmetic In Vitro Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cosmetic In Vitro Testing Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cosmetic In Vitro Testing Services industry.
Chapter 3: Detailed analysis of Cosmetic In Vitro Testing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Cosmetic In Vitro Testing Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Cosmetic In Vitro Testing Services in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Biological Assays
- Non-cell-based Assays
Applications
- Hair Care
- Skin Care
- Others
Companies covered
- SGS
- Intertek
- Eurofins Scientific
- Abich
- XCellR8
- ImQuest BioSciences
- INVITRO-CONNECT
- Labcorp
- Bio-Rad Laboratories
- Qiagen
- GE Healthcare
- Charles River Laboratories International
- Catalent
- Evotec Cyprotex
- Promega
- Gentronix Limited
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Cosmetic In Vitro Testing Services Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Cosmetic In Vitro Testing Services Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Cosmetic In Vitro Testing Services Market Dynamics
- 2.1 Cosmetic In Vitro Testing Services Industry Trends
- 2.2 Cosmetic In Vitro Testing Services Industry Drivers
- 2.3 Cosmetic In Vitro Testing Services Industry Opportunities and Challenges
- 2.4 Cosmetic In Vitro Testing Services Industry Restraints
3 Cosmetic In Vitro Testing Services Market by Company
- 3.1 Global Cosmetic In Vitro Testing Services Company Revenue Ranking in 2025
- 3.2 Global Cosmetic In Vitro Testing Services Revenue by Company (2021-2026)
- 3.3 Global Cosmetic In Vitro Testing Services Company Ranking (2024-2026)
- 3.4 Global Cosmetic In Vitro Testing Services Company Manufacturing Base and Headquarters
- 3.5 Global Cosmetic In Vitro Testing Services Company Product Type and Application
- 3.6 Global Cosmetic In Vitro Testing Services Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Cosmetic In Vitro Testing Services Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Cosmetic In Vitro Testing Services Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Cosmetic In Vitro Testing Services Market by Type
- 4.1 Cosmetic In Vitro Testing Services Type Introduction
- 4.1.1 Biological Assays
- 4.1.2 Non-cell-based Assays
- 4.2 Global Cosmetic In Vitro Testing Services Sales Value by Type
- 4.2.1 Global Cosmetic In Vitro Testing Services Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Cosmetic In Vitro Testing Services Sales Value by Type (2021-2032)
- 4.2.3 Global Cosmetic In Vitro Testing Services Sales Value Share by Type (2021-2032)
5 Cosmetic In Vitro Testing Services Market by Application
- 5.1 Cosmetic In Vitro Testing Services Application Introduction
- 5.1.1 Hair Care
- 5.1.2 Skin Care
- 5.1.3 Others
- 5.2 Global Cosmetic In Vitro Testing Services Sales Value by Application
- 5.2.1 Global Cosmetic In Vitro Testing Services Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Cosmetic In Vitro Testing Services Sales Value by Application (2021-2032)
- 5.2.3 Global Cosmetic In Vitro Testing Services Sales Value Share by Application (2021-2032)
6 Cosmetic In Vitro Testing Services Regional Value Analysis
- 6.1 Global Cosmetic In Vitro Testing Services Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Cosmetic In Vitro Testing Services Sales Value by Region (2021-2032)
- 6.2.1 Global Cosmetic In Vitro Testing Services Sales Value by Region: 2021-2026
- 6.2.2 Global Cosmetic In Vitro Testing Services Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Cosmetic In Vitro Testing Services Sales Value (2021-2032)
- 6.3.2 North America Cosmetic In Vitro Testing Services Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Cosmetic In Vitro Testing Services Sales Value (2021-2032)
- 6.4.2 Europe Cosmetic In Vitro Testing Services Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Cosmetic In Vitro Testing Services Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Cosmetic In Vitro Testing Services Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Cosmetic In Vitro Testing Services Sales Value (2021-2032)
- 6.6.2 South America Cosmetic In Vitro Testing Services Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Cosmetic In Vitro Testing Services Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Cosmetic In Vitro Testing Services Sales Value Share by Country, 2025 VS 2032
7 Cosmetic In Vitro Testing Services Country-level Value Analysis
- 7.1 Global Cosmetic In Vitro Testing Services Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Cosmetic In Vitro Testing Services Sales Value by Country (2021-2032)
- 7.2.1 Global Cosmetic In Vitro Testing Services Sales Value by Country (2021-2026)
- 7.2.2 Global Cosmetic In Vitro Testing Services Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.7.2 France Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.14.2 China Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.17.2 India Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Cosmetic In Vitro Testing Services Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Cosmetic In Vitro Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Cosmetic In Vitro Testing Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 SGS
- 8.1.1 SGS Company Information
- 8.1.2 SGS Business Overview
- 8.1.3 SGS Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 8.1.4 SGS Cosmetic In Vitro Testing Services Product Portfolio
- 8.1.5 SGS Recent Developments
- 8.2 Intertek
- 8.2.1 Intertek Company Information
- 8.2.2 Intertek Business Overview
- 8.2.3 Intertek Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 8.2.4 Intertek Cosmetic In Vitro Testing Services Product Portfolio
- 8.2.5 Intertek Recent Developments
- 8.3 Eurofins Scientific
- 8.3.1 Eurofins Scientific Company Information
- 8.3.2 Eurofins Scientific Business Overview
- 8.3.3 Eurofins Scientific Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 8.3.4 Eurofins Scientific Cosmetic In Vitro Testing Services Product Portfolio
- 8.3.5 Eurofins Scientific Recent Developments
- 8.4 Abich
- 8.4.1 Abich Company Information
- 8.4.2 Abich Business Overview
- 8.4.3 Abich Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 8.4.4 Abich Cosmetic In Vitro Testing Services Product Portfolio
- 8.4.5 Abich Recent Developments
- 8.5 XCellR8
- 8.5.1 XCellR8 Company Information
- 8.5.2 XCellR8 Business Overview
- 8.5.3 XCellR8 Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 8.5.4 XCellR8 Cosmetic In Vitro Testing Services Product Portfolio
- 8.5.5 XCellR8 Recent Developments
- 8.6 ImQuest BioSciences
- 8.6.1 ImQuest BioSciences Company Information
- 8.6.2 ImQuest BioSciences Business Overview
- 8.6.3 ImQuest BioSciences Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 8.6.4 ImQuest BioSciences Cosmetic In Vitro Testing Services Product Portfolio
- 8.6.5 ImQuest BioSciences Recent Developments
- 8.7 INVITRO-CONNECT
- 8.7.1 INVITRO-CONNECT Company Information
- 8.7.2 INVITRO-CONNECT Business Overview
- 8.7.3 INVITRO-CONNECT Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 8.7.4 INVITRO-CONNECT Cosmetic In Vitro Testing Services Product Portfolio
- 8.7.5 INVITRO-CONNECT Recent Developments
- 8.8 Labcorp
- 8.8.1 Labcorp Company Information
- 8.8.2 Labcorp Business Overview
- 8.8.3 Labcorp Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 8.8.4 Labcorp Cosmetic In Vitro Testing Services Product Portfolio
- 8.8.5 Labcorp Recent Developments
- 8.9 Bio-Rad Laboratories
- 8.9.1 Bio-Rad Laboratories Company Information
- 8.9.2 Bio-Rad Laboratories Business Overview
- 8.9.3 Bio-Rad Laboratories Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 8.9.4 Bio-Rad Laboratories Cosmetic In Vitro Testing Services Product Portfolio
- 8.9.5 Bio-Rad Laboratories Recent Developments
- 8.10 Qiagen
- 8.10.1 Qiagen Company Information
- 8.10.2 Qiagen Business Overview
- 8.10.3 Qiagen Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 8.10.4 Qiagen Cosmetic In Vitro Testing Services Product Portfolio
- 8.10.5 Qiagen Recent Developments
- 8.11 GE Healthcare
- 8.11.1 GE Healthcare Company Information
- 8.11.2 GE Healthcare Business Overview
- 8.11.3 GE Healthcare Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 8.11.4 GE Healthcare Cosmetic In Vitro Testing Services Product Portfolio
- 8.11.5 GE Healthcare Recent Developments
- 8.12 Charles River Laboratories International
- 8.12.1 Charles River Laboratories International Company Information
- 8.12.2 Charles River Laboratories International Business Overview
- 8.12.3 Charles River Laboratories International Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 8.12.4 Charles River Laboratories International Cosmetic In Vitro Testing Services Product Portfolio
- 8.12.5 Charles River Laboratories International Recent Developments
- 8.13 Catalent
- 8.13.1 Catalent Company Information
- 8.13.2 Catalent Business Overview
- 8.13.3 Catalent Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 8.13.4 Catalent Cosmetic In Vitro Testing Services Product Portfolio
- 8.13.5 Catalent Recent Developments
- 8.14 Evotec Cyprotex
- 8.14.1 Evotec Cyprotex Company Information
- 8.14.2 Evotec Cyprotex Business Overview
- 8.14.3 Evotec Cyprotex Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 8.14.4 Evotec Cyprotex Cosmetic In Vitro Testing Services Product Portfolio
- 8.14.5 Evotec Cyprotex Recent Developments
- 8.15 Promega
- 8.15.1 Promega Company Information
- 8.15.2 Promega Business Overview
- 8.15.3 Promega Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 8.15.4 Promega Cosmetic In Vitro Testing Services Product Portfolio
- 8.15.5 Promega Recent Developments
- 8.16 Gentronix Limited
- 8.16.1 Gentronix Limited Company Information
- 8.16.2 Gentronix Limited Business Overview
- 8.16.3 Gentronix Limited Cosmetic In Vitro Testing Services Revenue and Gross Margin (2021-2026)
- 8.16.4 Gentronix Limited Cosmetic In Vitro Testing Services Product Portfolio
- 8.16.5 Gentronix Limited Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst